Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamoxifen versus gonadotropin for ovulation induction in infertile women with polycystic ovary syndrome undergoing IUI
IRCT20250517065763N3Phase 3Completed
- Sponsor
- Jahrom University of Medical Sciences
- Start
- Dec 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of tamoxifen in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Jahrom University of Medical Sciences. Primary endpoint: Therapeutic results / efficacy. Started Dec 2025; status: completed.
02
Drugs
tamoxifen
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT20250517065763N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250517065763N3.